1,000
Participants
Start Date
June 8, 2021
Primary Completion Date
June 1, 2027
Study Completion Date
June 1, 2037
Predictive model
Patient who have not had immunotherapy will have tumour tested using the predictive model. This determines whether patients are likely to respond, or not to respond to immunotherapy. Results of the predictive model will be compared with the actual response to immunotherapy when this has been completed.
RECRUITING
Chris O'Brien Lifehouse, Sydney
RECRUITING
Melanoma Institute Australia, Sydney
RECRUITING
Westmead Hospital, Sydney
Melanoma Institute Australia
OTHER